Merdica Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 17-11-2024
- Paid Up Capital ₹ 0.50 M
as on 17-11-2024
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 30.69%
(FY 2023)
- Profit 12.52%
(FY 2023)
- Ebitda 84.73%
(FY 2023)
- Net Worth 42.91%
(FY 2023)
- Total Assets 132.10%
(FY 2023)
About Merdica
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Vinay Sharma and Supriya Sharma serve as directors at the Company.
- CIN/LLPIN
U24100DL2020PTC362939
- Company No.
362939
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Mar 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Merdica Private Limited offer?
Merdica Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Diabetes Medicine, Blood Pressure Medicine, Cardiac Drugs, Pharma & Bioanalytical Services, PCD Pharma Franchise, Antianginal Drugs, Common Disease Medicines, Pharmaceutical Medicine, Anticoagulant and Antiplatelet Drugs.
Who are the key members and board of directors at Merdica?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Sharma  | Director | 18-Mar-2020 | Current |
| Supriya Sharma | Director | 18-Mar-2020 | Current |
Financial Performance of Merdica.
Merdica Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30.69% increase. The company also saw a substantial improvement in profitability, with a 12.52% increase in profit. The company's net worth Soared by an impressive increase of 42.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Merdica?
Unlock access to Merdica's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Merdica?
Merdica has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Merdica, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Merdica's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
